These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 7851559)
1. Malignant peripheral nerve sheath tumors in patients with and without neurofibromatosis. Doorn PF; Molenaar WM; Buter J; Hoekstra HJ Eur J Surg Oncol; 1995 Feb; 21(1):78-82. PubMed ID: 7851559 [TBL] [Abstract][Full Text] [Related]
2. Soft-tissue sarcomas in children and adolescents with neurofibromatosis type 1. Ferrari A; Bisogno G; Macaluso A; Casanova M; D'Angelo P; Pierani P; Zanetti I; Alaggio R; Cecchetto G; Carli M Cancer; 2007 Apr; 109(7):1406-12. PubMed ID: 17330850 [TBL] [Abstract][Full Text] [Related]
3. Malignant peripheral nerve sheath tumors: prognostic factors and survival in a series of patients treated at a single institution. Anghileri M; Miceli R; Fiore M; Mariani L; Ferrari A; Mussi C; Lozza L; Collini P; Olmi P; Casali PG; Pilotti S; Gronchi A Cancer; 2006 Sep; 107(5):1065-74. PubMed ID: 16881077 [TBL] [Abstract][Full Text] [Related]
4. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors. Watson KL; Al Sannaa GA; Kivlin CM; Ingram DR; Landers SM; Roland CL; Cormier JN; Hunt KK; Feig BW; Ashleigh Guadagnolo B; Bishop AJ; Wang WL; Slopis JM; McCutcheon IE; Lazar AJ; Torres KE J Neurosurg; 2017 Jan; 126(1):319-329. PubMed ID: 27035165 [TBL] [Abstract][Full Text] [Related]
5. Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome. Zou C; Smith KD; Liu J; Lahat G; Myers S; Wang WL; Zhang W; McCutcheon IE; Slopis JM; Lazar AJ; Pollock RE; Lev D Ann Surg; 2009 Jun; 249(6):1014-22. PubMed ID: 19474676 [TBL] [Abstract][Full Text] [Related]
7. Management of childhood malignant peripheral nerve sheath tumor. Ferrari A; Bisogno G; Carli M Paediatr Drugs; 2007; 9(4):239-48. PubMed ID: 17705563 [TBL] [Abstract][Full Text] [Related]
8. Malignant peripheral nerve sheath tumors in neurofibromatosis 1. King AA; Debaun MR; Riccardi VM; Gutmann DH Am J Med Genet; 2000 Aug; 93(5):388-92. PubMed ID: 10951462 [TBL] [Abstract][Full Text] [Related]
9. Malignant peripheral nerve sheath tumors (MPNST) in NF1-affected children. Friedrich RE; Hartmann M; Mautner VF Anticancer Res; 2007; 27(4A):1957-60. PubMed ID: 17649804 [TBL] [Abstract][Full Text] [Related]
10. Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO). Valentin T; Le Cesne A; Ray-Coquard I; Italiano A; Decanter G; Bompas E; Isambert N; Thariat J; Linassier C; Bertucci F; Bay JO; Bellesoeur A; Penel N; Le Guellec S; Filleron T; Chevreau C Eur J Cancer; 2016 Mar; 56():77-84. PubMed ID: 26824706 [TBL] [Abstract][Full Text] [Related]
11. Histopathology and clinical outcome of NF1-associated vs. sporadic malignant peripheral nerve sheath tumors. Hagel C; Zils U; Peiper M; Kluwe L; Gotthard S; Friedrich RE; Zurakowski D; von Deimling A; Mautner VF J Neurooncol; 2007 Apr; 82(2):187-92. PubMed ID: 17111191 [TBL] [Abstract][Full Text] [Related]
12. Atypical and malignant peripheral nerve-sheath tumors of the brachial plexus: report of three cases and review of the literature. Rawal A; Yin Q; Roebuck M; Sinopidis C; Kalogrianitis S; Helliwell TR; Frostick S Microsurgery; 2006; 26(2):80-6. PubMed ID: 16538633 [TBL] [Abstract][Full Text] [Related]
13. Early outcomes for malignant peripheral nerve sheath tumor treated with chemotherapy. Moretti VM; Crawford EA; Staddon AP; Lackman RD; Ogilvie CM Am J Clin Oncol; 2011 Aug; 34(4):417-21. PubMed ID: 20838322 [TBL] [Abstract][Full Text] [Related]
14. Gender dimorphism and age of onset in malignant peripheral nerve sheath tumor preclinical models and human patients. Shurell E; Tran LM; Nakashima J; Smith KB; Tam BM; Li Y; Dry SM; Federman N; Tap WD; Wu H; Eilber FC BMC Cancer; 2014 Nov; 14():827. PubMed ID: 25398666 [TBL] [Abstract][Full Text] [Related]
15. Benign whole body tumor volume is a risk factor for malignant peripheral nerve sheath tumors in neurofibromatosis type 1. Nguyen R; Jett K; Harris GJ; Cai W; Friedman JM; Mautner VF J Neurooncol; 2014 Jan; 116(2):307-13. PubMed ID: 24166582 [TBL] [Abstract][Full Text] [Related]